XML 92 R2.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 39,884 $ 49,348
Marketable securities available-for-sale 111,171 96,188
Accounts and other receivables, net 8,886 3,704
Inventories, net 41,332 19,022
Prepaid expenses and other current assets 7,380 6,102
Total current assets 208,653 174,364
Property and equipment, net 32,022 17,064
Intangible assets, net 2,500 11,717
Operating lease right-of-use assets 30,252  
Goodwill 2,081 2,144
Restricted cash 216 619
Other assets 3,344 4,976
Total assets 279,068 210,884
Current liabilities:    
Accounts payable 9,278 5,278
Accrued research and development 4,120 9,714
Accrued liabilities 14,802 16,041
Warrant liability 14,860  
Other current liabilities 9,987 7,000
Total current liabilities 53,047 38,033
Long-term debt, net 178,601 100,871
Long-term portion of lease liabilities 37,845  
Other long-term liabilities 1,285 8,915
Total liabilities 270,778 147,819
Commitments and contingencies (Note 9)
Stockholders’ equity:    
Preferred stock value
Common stock: $0.001 par value; 139,000 shares authorized at December 31, 2019 and 2018; 83,871 and 62,862 shares issued and outstanding at December 31, 2019 and 2018, respectively 84 63
Additional paid-in capital 1,229,417 1,131,241
Accumulated other comprehensive loss (2,387) (2,015)
Accumulated deficit (1,218,824) (1,066,224)
Total stockholders’ equity 8,290 63,065
Total liabilities and stockholders’ equity 279,068 210,884
Series B Convertible Preferred Stock    
Stockholders’ equity:    
Preferred stock value